Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Benazzi
F
F
D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002998:Clonazepam / Q000008:administration & dosage / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D003891:Desipramine / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D016584:Panic Disorder / Q000188:drug therapy* / Q000523:psychology; D010879:Piperazines; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D003511:Cyclohexanols; D010879:Piperazines; D014230:Triazoles; D005473:Fluoxetine; C051752:nefazodone; D002998:Clonazepam; D000069470:Venlafaxine Hydrochloride; D003891:Desipramine